ByteDance seeks nearly $200 million for AI drug discovery spinoff

The new Shanghai-based company is being carved out at an implied valuation of about $1 billion, while ByteDance is expected to keep control and transfer key assets into the entity.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.